Home LiteratureArticle Details
PMID: 20957176 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.

PloS one ·Vol. 5 ·No. 10 ·2010-10-04

Elson-Schwab I, Lorentzen A, Marshall CJ

Abstract

A functional role of microRNAs (miRNAs or miRs) in neoplasia and metastasis is becoming clear, and the miR-200 family has received much attention for potentially regulating tumor progression. The miRNAs of this family have been shown to suppress epithelial-mesenchymal transition, and their down-regulation in some tumors promotes invasion and metastasis. Interestingly, while miR-200 is down-regulated in some cancers, it is up-regulated in others. We show that levels of miR-200 are increased in melanoma cell lines compared to normal melanocytes and that miR-200 family members play a role in determining modes of tumor cell migration. Individual tumor cells can invade in either elongated, "mesenchymal-type" or rounded, "amoeboid-like" modes and these two modes of invasion are inter-convertible [1]. In melanoma cell lines, expression of miR-200 members does not suppress invasion but rather leads to a switch between modes of invasion. MicroRNA-200c results in a higher proportion of cells adopting the rounded, amoeboid-like mode of invasion, while miR-200a results in a protrusion-associated elongated mode of invasion. Functional target identification studies suggest that the morphological effects of miR-200c may be mediated by reduced expression of MARCKS, which has been linked to formation of cell protrusions. In contrast miR-200a reduces actomyosin contractility, a feature of rounded morphology. Overall our findings call into question the general role of miR-200 in suppressing invasion and metastasis, and highlight novel distinguishing characteristics of individual miR-200 family members.

MeSH Terms
Humans Intracellular Signaling Peptides and Proteins/physiology Melanoma/pathology Membrane Proteins/physiology Myristoylated Alanine-Rich C Kinase Substrate Neoplasm Invasiveness
Chemicals
Intracellular Signaling Peptides and Proteins MARCKS protein, human Membrane Proteins Myristoylated Alanine-Rich C Kinase Substrate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Elson-Schwab Ilan
Cancer Research UK Centre for Cell and Molecular Biology, Institute of Cancer Research, London, United Kingdom.
Lorentzen Anna
Marshall Christopher J
References (44)
44 references, click to expand
  1. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network.
    Carcinogenesis. 2010 Apr;31(4):559-66 PMID: 20053927
  2. Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR.
    Cell Cycle. 2006 Sep;5(17):1951-6 PMID: 16929162
  3. Critical determinants of cancer metastasis: rationale for therapy.
    Cancer Chemother Pharmacol. 1999;43 Suppl:S3-10 PMID: 10357552
  4. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression.
    Cell Cycle. 2009 Jul 1;8(13):2064-9 PMID: 19502803
  5. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.
    Cell Res. 2008 May;18(5):549-57 PMID: 18379589
  6. Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane.
    Nature. 1991 May 23;351(6324):320-2 PMID: 2034276
  7. DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells.
    Curr Biol. 2008 Oct 14;18(19):1456-65 PMID: 18835169
  8. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
    Cancer Biol Ther. 2009 Nov;8(21):2013-24 PMID: 20037478
  9. MicroRNAs accurately identify cancer tissue origin.
    Nat Biotechnol. 2008 Apr;26(4):462-9 PMID: 18362881
  10. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion.
    Nat Cell Biol. 2005 Mar;7(3):255-61 PMID: 15723050
  11. Endogenous human microRNAs that suppress breast cancer metastasis.
    Nature. 2008 Jan 10;451(7175):147-52 PMID: 18185580
  12. Rac activation and inactivation control plasticity of tumor cell movement.
    Cell. 2008 Oct 31;135(3):510-23 PMID: 18984162
  13. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs.
    RNA. 2007 Nov;13(11):1894-910 PMID: 17872505
  14. miR-200 enhances mouse breast cancer cell colonization to form distant metastases.
    PLoS One. 2009 Sep 29;4(9):e7181 PMID: 19787069
  15. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.
    Cancer Res. 2007 Sep 1;67(17):7972-6 PMID: 17804704
  16. PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE.
    Nat Cell Biol. 2008 Feb;10(2):127-37 PMID: 18204440
  17. MicroRNA signatures in human ovarian cancer.
    Cancer Res. 2007 Sep 15;67(18):8699-707 PMID: 17875710
  18. Prognostic Values of microRNAs in Colorectal Cancer.
    Biomark Insights. 2006;2:113-121 PMID: 18079988
  19. Dynamic adhesions and MARCKS in melanoma cells.
    J Cell Sci. 2009 Jul 1;122(Pt 13):2300-10 PMID: 19509053
  20. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
    EMBO Rep. 2008 Jun;9(6):582-9 PMID: 18483486
  21. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Genes Dev. 2008 Apr 1;22(7):894-907 PMID: 18381893
  22. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis.
    J Cell Biol. 2003 Jan 20;160(2):267-77 PMID: 12527751
  23. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
    Biochem Biophys Res Commun. 2009 Jun 5;383(3):280-5 PMID: 19302977
  24. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion.
    J Biol Chem. 2009 Nov 27;284(48):33019-29 PMID: 19801681
  25. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
    Int J Cancer. 2010 Jan 1;126(1):114-24 PMID: 19569050
  26. Widespread changes in protein synthesis induced by microRNAs.
    Nature. 2008 Sep 4;455(7209):58-63 PMID: 18668040
  27. uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180.
    J Cell Biol. 2008 Aug 25;182(4):777-90 PMID: 18725541
  28. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology.
    Neuron. 2005 Oct 6;48(1):77-90 PMID: 16202710
  29. Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation.
    Cancer Res. 1998 Apr 1;58(7):1429-34 PMID: 9537244
  30. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.
    J Invest Dermatol. 2009 Jul;129(7):1740-51 PMID: 19212343
  31. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
    Cell. 2005 Jan 14;120(1):15-20 PMID: 15652477
  32. Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.
    Cell. 2009 Dec 11;139(6):1096-108 PMID: 20005803
  33. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Nat Cell Biol. 2008 May;10(5):593-601 PMID: 18376396
  34. Altered MicroRNA expression in cervical carcinomas.
    Clin Cancer Res. 2008 May 1;14(9):2535-42 PMID: 18451214
  35. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    J Biol Chem. 2008 May 30;283(22):14910-4 PMID: 18411277
  36. Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation.
    Mol Carcinog. 2010 Feb;49(2):175-82 PMID: 19852062
  37. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation.
    Toxicol Appl Pharmacol. 2009 Mar 15;235(3):305-11 PMID: 19167416
  38. Circulating microRNAs as stable blood-based markers for cancer detection.
    Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8 PMID: 18663219
  39. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
    Mol Cancer Ther. 2009 May;8(5):1055-66 PMID: 19435871
  40. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.
    Oncogene. 2010 Jul 29;29(30):4297-306 PMID: 20514023
  41. The impact of microRNAs on protein output.
    Nature. 2008 Sep 4;455(7209):64-71 PMID: 18668037
  42. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.
    Nat Cell Biol. 2003 Aug;5(8):711-9 PMID: 12844144
  43. MARCKS protein is transcriptionally down-regulated in v-Src-transformed BALB/c 3T3 cells.
    J Biol Chem. 1992 Jan 15;267(2):1327-30 PMID: 1370466
  44. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.
    Gastroenterology. 2006 Jun;130(7):2113-29 PMID: 16762633
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2010-10-04
Epub
2010-00-04
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC2949394
Subset
IM
Grants
Cancer Research UK · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]